Antibodies for the treatment of bacterial infections: current experience and future prospects

被引：76

作者：

Bebbington, Christopher ^{[1
]}

Yarranton, Geoffrey ^{[1
]}

机构：

[1] KaloBios Pharmaceut Inc, San Francisco, CA 94080 USA

来源：

CURRENT OPINION IN BIOTECHNOLOGY | 2008年 / 19卷 / 06期

关键词：

D O I：

10.1016/j.copbio.2008.10.002

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Antibodies can be used for the prevention and treatment of bacterial infections in animal models of disease. Current antibody technology allows the generation of high affinity human/humanized antibodies that can be optimized for antibacterial activity and in vivo biodistribution and pharmacokinetics. Such antibodies have exquisite selectivity for their bacterial target antigen and promise efficacy and safety. Why are there no monoclonal antibody products approved for the treatment or prevention of bacterial infections? Can antibodies succeed where antibiotics are failing? Some antibody therapies are currently being evaluated in clinical trials but several have failed despite positive data in animal disease models. This review will discuss the pros and cons of antibody therapeutics targeted at bacterial infections.

引用

页码：613 / 619

页数：7

共 51 条

[1] Human botulism immune globulin for the treatment of infant botulism [J].

Arnon, SS ;

Schechter, R ;

Maslanka, SE ;

Jewell, NP ;

Hatheway, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (05) :462-471

[2] S. aureus IgG-binding proteins SpA and Sbi:: Host speciticity and mechanisms of immune complex formation [J].

Atkins, Karen L. ;

Burman, Julia D. ;

Chamberlain, Emily S. ;

Cooper, Jessica E. ;

Poutrel, Bernard ;

Bagby, Stefan ;

Jenkins, A. Toby A. ;

Feil, Edward J. ;

van den Elsen, Jean M. H. .

MOLECULAR IMMUNOLOGY, 2008, 45 (06) :1600-1611

[3] Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters [J].

Babcock, Gregory J. ;

Broering, Teresa J. ;

Hernandez, Hector J. ;

Mandell, Robert B. ;

Donahue, Katherine ;

Boatright, Naomi ;

Stack, Anne M. ;

Lowy, Israel ;

Graziano, Robert ;

Molrine, Deborah ;

Ambrosino, Donna M. ;

Thomas, William D., Jr. .

INFECTION AND IMMUNITY, 2006, 74 (11) :6339-6347

[4]

BABIN M, 2003, 43 INT C ANT AG CHEM

[5] Investigating antibody-catalyzed ozone generation by human neutrophils [J].

Babior, BM ;

Takeuchi, C ;

Ruedi, J ;

Gutierrez, A ;

Wentworth, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (06) :3031-3034

[6] The Pseudomonas aeruginosa secretory product pyocyanin inactivates α1 protease inhibitor:: Implications for the pathogenesis of cystic fibrosis lung disease [J].

Britigan, BE ;

Railsback, MA ;

Cox, CD .

INFECTION AND IMMUNITY, 1999, 67 (03) :1207-1212

[7] Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections [J].

Burnie, JP ;

Matthews, RC ;

Carter, T ;

Beaulieu, E ;

Donohoe, M ;

Chapman, C ;

Williamson, P ;

Hodgetts, SJ .

INFECTION AND IMMUNITY, 2000, 68 (06) :3200-3209

[8] The biology and future prospects of antivirulence therapies [J].

Cegelski, Lynette ;

Marshall, Garland R. ;

Eldridge, Gary R. ;

Hultgren, Scott J. .

NATURE REVIEWS MICROBIOLOGY, 2008, 6 (01) :17-27

[9] Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-β-(1-6)-glucosaminev [J].

Cerca, Nuno ;

Jefferson, Kimberly K. ;

Maira-Litran, Tomas ;

Pier, Danielle B. ;

Kelly-Quintos, Casie ;

Goldmann, Donald A. ;

Azeredo, Joana ;

Pier, Gerald B. .

INFECTION AND IMMUNITY, 2007, 75 (07) :3406-3413

[10] Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state [J].

Cerca, Nuno ;

Jefferson, Kimberly K. ;

Oliveira, Rosario ;

Pier, Gerald B. ;

Azeredo, Joana .

INFECTION AND IMMUNITY, 2006, 74 (08) :4849-4855

← 1 2 3 4 5 6 →